US Broker Ratings

Exact Sciences Corporation (EXAS) Stock Analysis: 20% Potential Upside Captures Investor Attention

Exact Sciences Corporation (NASDAQ: EXAS), a prominent player in the healthcare sector, specializes in diagnostics and research with a focus on innovative cancer screening and diagnostic tests. With a current..

Centene Corporation (CNC) Investor Outlook: Navigating Healthcare with a 6.82% Potential Upside

Centene Corporation (NYSE: CNC), a stalwart in the healthcare sector, presents a nuanced opportunity for investors navigating the complex healthcare plans industry. With a market capitalization of $15.6 billion, Centene..

Regencell Bioscience Holdings L (RGC) Investor Outlook: A Hong Kong Biotech’s Rollercoaster Year with a 52-Week Range from $0.09 to $78.00

Regencell Bioscience Holdings Limited (NASDAQ: RGC) stands out in the healthcare sector, specifically within the drug manufacturers specializing in Traditional Chinese Medicine (TCM). Headquartered in Causeway Bay, Hong Kong, this..

Tempus AI, Inc. (TEM) Stock Analysis: Balancing Growth with Valuation Challenges in the Health Information Sector

Tempus AI, Inc. (TEM), a notable player in the health information services industry, is capturing investor attention with its robust expansion in the healthcare technology sector. With a market capitalization..

HealthEquity, Inc. (HQY) Stock Analysis: A 30% Upside Potential Beckons Investors

HealthEquity, Inc. (NASDAQ: HQY) is carving out a significant niche within the healthcare sector, specifically in the health information services industry. With a market capitalization of $8.08 billion, the company..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Strong Buy Ratings Point to a Promising 15.85% Upside

As a prominent player in the healthcare sector, Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is making notable strides with its innovative contributions to the drug manufacturing industry, focusing on specialty and..

Walgreens Boots Alliance (WBA): Investor Outlook with 8.35% Dividend Yield and Strategic Global Footprint

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) stands as a notable player in the healthcare sector, specifically within the pharmaceutical retail industry. With its roots dating back to 1909, this Deerfield,..

Charles River Laboratories (CRL) Stock Analysis: Navigating Potential 14.38% Upside in the Healthcare Sector

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a pivotal player in the healthcare sector, particularly in the diagnostics and research industry. With a current market capitalization of $7.65..

Avantor, Inc. (AVTR): Investor Outlook Reveals Potential Upside and Strategic Positioning in Healthcare

Avantor, Inc. (NYSE: AVTR), a prominent player in the Healthcare sector, stands at a pivotal juncture, drawing attention from investors eager to explore its potential upside. With a market capitalization..

AbbVie Inc. (ABBV): Investor Outlook with a Robust 112.85% Return on Equity and Solid Dividend Yield

AbbVie Inc. (NYSE: ABBV), a titan in the healthcare sector, continues to captivate investor attention with its impressive financial metrics and strong product portfolio. As a key player in the..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Unveiling a 17% Potential Upside for Healthcare Investors

GE HealthCare Technologies Inc. (NYSE: GEHC) is making waves in the healthcare sector with its promising growth prospects and robust product offerings. With a market capitalization of $34.2 billion, this..

Veeva Systems Inc. (VEEV) Stock Analysis: Potential 14% Upside and Strong Analyst Support

Veeva Systems Inc. (NYSE: VEEV), a key player in the healthcare sector, continues to draw investor interest with its robust cloud-based software solutions tailored for the life sciences industry. Headquartered..

Bio-Techne Corp (TECH) Stock Report: Understanding the Potential Upside with a 24.61% Growth Outlook

Bio-Techne Corp (NASDAQ: TECH) is a prominent player in the biotechnology sector, with a market capitalization of $8.27 billion. Headquartered in Minneapolis, Minnesota, Bio-Techne develops and manufactures a wide array..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A Promising 45% Upside with Strong Buy Ratings

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology industry, is making waves with its promising growth potential and robust pipeline. Headquartered in Dublin, Ireland, Jazz Pharmaceuticals operates..

Ascendis Pharma A/S (ASND): Investor Outlook Highlights 27% Potential Upside with Strong Buy Ratings

Ascendis Pharma A/S (ASND), a dynamic player in the healthcare sector, is making significant waves in the biotechnology industry from its base in Hellerup, Denmark. With a robust market capitalization..

BioMarin Pharmaceutical Inc. (BMRN) Investor Outlook: Unveiling a 77.69% Potential Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a prominent player in the biotechnology sector, offers intriguing opportunities for investors seeking exposure to the healthcare industry. With a market capitalization of $10.44 billion,..

Labcorp Holdings Inc. (LH) Stock Analysis: Assessing Its Market Position and Growth Potential

Labcorp Holdings Inc. (NYSE: LH), a major player in the healthcare sector, is a leader in the diagnostics and research industry. Headquartered in Burlington, North Carolina, Labcorp’s operations span a..

Moderna, Inc. (MRNA) Stock Analysis: Unpacking the 75% Potential Upside Amidst Market Challenges

Moderna, Inc. (NASDAQ: MRNA), a pioneer in the biotechnology sector, has captured global attention with its innovative mRNA-based medicines. Headquartered in Cambridge, Massachusetts, Moderna has made significant strides in developing..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Unveiling a 16.58% Potential Upside in the Healthcare Sector

Bio-Rad Laboratories, Inc. (NYSE: BIO), a prominent player in the healthcare sector, is capturing investor attention with its substantial foothold in the medical devices industry. Headquartered in Hercules, California, and..

Solventum Corporation (SOLV) Stock Analysis: Exploring a 17% Upside Potential in the Healthcare Sector

Solventum Corporation (SOLV) is carving out a robust niche within the healthcare sector, particularly in the Medical Instruments & Supplies industry. With a market capitalization of $12.78 billion, the company..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds